§ Funding Round
Series C funding round for Bluejay Therapeutics raising $180M in May 2024
Series C funding round for Bluejay Therapeutics raising $180M in May 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Angel | eric shiozaki | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Westlake Village BioPartners | — | — |
| Organization | — | |
daniel estesLEAD | Angel | daniel estes |
HBM Healthcare Investments | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
RiverVest Venture Partners | — | — |
T. Rowe Price Associates | — | — |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$221M
Top Valuation
-
Bluejay Therapeutics raised $180M in a Series C round.
The round was announced on 05/01/24.
The round was led by daniel estes.
